J.P. Morgan Overweight On Nu Skin Enterprises (NUS)

J.P. Morgan Chase & Co has an Overweight rating Nu Skin Enterprises NUS and $37 price target on shares. In a note to investors, J.P. Morgan writes, "NUS (OW) provided an update on issues surrounding their Japanese business, which appear to be more one-time in nature than we expected. NUS also provided their initial Q1 results, which were better than our original estimates, despite the impact from Japan. NUS also reiterated their FY11 guidance range of $2.25-$2.35 and increased their Q1 EPS guidance range to $0.52-$0.54 (from $0.50-$0.53)." Shares of NUS gained $1.81 yesterday to close at $30.57, a gain of 6.3%.